Why the study?
Does percutaneous mitral valvuloplasty using the Inoue Balloon improve mitral valve area and provide long-term restenosis-free survival in patients requiring mitral intervention?
Does percutaneous mitral valvuloplasty using the Inoue Balloon improve mitral valve area and provide long-term restenosis-free survival in patients requiring mitral intervention?
Percutaneous mitral valvuloplasty using the Inoue Balloon provides a high initial success rate and a median restenosis-free survival of approximately 7 years, with outcomes influenced by age, echo score, and pre-procedural valve area.
May support Inoue balloon PMV in selected mitral stenosis; leaves open need for randomized trials on long-term durability.
Background and Objectives:The objective of this study was to assess the short- and long-term clinical outcomes and valvular changes after percutaneous mitral valvuloplasty (PMV) in Sejong Hospital. Subjects and Methods: Four hundred sixty-seven patients received PMV using the Inoue Balloon at Sejong hospital from 1990 to 2002. Short and long-term results, restenosis-free survival rate and prognostic factors for each result were analyzed by Chi-square, Cox regression analysis, Life table method and Cox proportional hazard model. Results:After PMV, mitral valve area increased from 0.94±0.21 cm2 to 1.76±0.37 cm2 and the success rate (MVA>1.5 cm2 or incre-ased by at least 50 % without the development of moderate to severe mitral regurgitation) was 78.9%. Age (≤50 years, p=0.018), echo score (≤9, p=0.05) and pre-procedural mitral valve area (MVA, ≥1.1 cm2, p=0.001) were independent favorable prognostic factors for short-term result. As for the development of moderate to severe mitral regurgitation, pre-procedural MVA (≤1.0 cm2, p=0.031) and echo score (>9, p=0.043) were independent predictive factors. Median restenosis-free survival was 82.98 months and the restenosis-free survival rate was 70.9 % at 3 years post-PMV, 48.1 % at 6 years and 29.6 % at 10 years. The independent prognostic factor for restenosis-free survival rate was left atrial dimension (LAD≤60 mm, p=0.015). In addition, echo score (≤8, p=0.412), pre-procedural MVA (≥1.0 cm2, p=0.24) and ejection fraction (EF≥55%, p=0.146) had an effect on
No takes yet. Share an insight, caveat, or question.
Jin et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: